Literature DB >> 32099966

Histone deacetylases in vascular permeability and remodeling associated with acute lung injury.

Laszlo Kovacs1, Anita Kovacs-Kasa2, Alexander D Verin2,3, David Fulton1,2, Rudolf Lucas1,2,3, Yunchao Su1,2,3,4.   

Abstract

Acute lung injury (ALI) is a severe progressive disorder that arises from a wide range of causes such as toxins or inflammation, resulting in significant morbidity and mortality. There are no effective therapeutic options apart from mechanical ventilation strategies. While the mechanisms that govern the clinically relevant process of increased EC permeability and remodeling associated with ALI are under intense investigation, our knowledge of the processes that determine barrier enhancement or preservation are far from completion. Recently, epigenetic mechanisms have emerged as a major regulator of enduring changes in cell behavior and the therapeutic potential of inhibiting histone deacetylases (HDACs) for the treatment of cardiovascular and inflammatory diseases has gained remarkable attention. Although HDACs have been shown to play an important role in regulating EC barrier function, the involved HDAC subtypes and mechanisms remain undefined. Further investigation of the HDAC signaling may provide therapeutic approaches for the prevention and treatment of ALI.

Entities:  

Keywords:  acute lung injury; endothelial barrier function; histone deacetylases

Year:  2018        PMID: 32099966      PMCID: PMC7041913          DOI: 10.20517/2574-1209.2018.06

Source DB:  PubMed          Journal:  Vessel Plus        ISSN: 2574-1209


  5 in total

1.  Identification of early and intermediate biomarkers for ARDS mortality by multi-omic approaches.

Authors:  S Y Liao; N G Casanova; C Bime; S M Camp; H Lynn; Joe G N Garcia
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.996

2.  HDAC inhibitor, MS-275, increases vascular permeability by suppressing Robo4 expression in endothelial cells.

Authors:  Taito Kashio; Keisuke Shirakura; Mayumi Kinoshita; Maaya Morita; Ryosuke Ishiba; Kosuke Muraoka; Tomoaki Kanbara; Masato Tanaka; Risa Funatsu; Nobumasa Hino; Shohei Koyama; Ryo Suzuki; Yasuo Yoshioka; Taiki Aoshi; Takefumi Doi; Yoshiaki Okada
Journal:  Tissue Barriers       Date:  2021-05-06

Review 3.  Molecular Mechanisms of Vascular Damage During Lung Injury.

Authors:  Ramon Bossardi Ramos; Alejandro Pablo Adam
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Vascular remodeling 2018: the updates.

Authors:  Evgenia Gerasimovskaya; Alexander Verin
Journal:  Vessel Plus       Date:  2019-04-17

5.  HDAC6 Activates ERK in Airway and Pulmonary Vascular Remodeling of Chronic Obstructive Pulmonary Disease.

Authors:  Yunchao Su; Weihong Han; Anita Kovacs-Kasa; Alexander D Verin; Laszlo Kovacs
Journal:  Am J Respir Cell Mol Biol       Date:  2021-12       Impact factor: 6.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.